Wheat bran is ac oncentrated source of insoluble fibre. Fibre intakes are generally lower than recommendations. This paper reviews the physiological effects of wheat bran and the health benefits it mayprovideinterms of the prevention of diseases such as colon and breast cancers, cardiovascular disease, obesity and gastrointestinal diseases.Inrecognition of the weight of evidence, the European Food Safety Authority has recently approved two health claims for wheat bran and gastrointestinal health.
Introduction
Wheat, at ype of grassp lant,i ss econd only to rice as the main human food crop.C ommercially, Tr iticum aestivum vulgare and Tr iticum turgidumd urum (hard wheat, mainly used in pasta products) are of most importance ( Macrae et al. 1993 ). The wheat grain or 'caryopsis', which is harvested for humannutrition, is composed of an umbero fd ifferent tissues: the germ (ore mbryo); the endosperm,w hichi sp ackedw ith starchg rains to provide energy forg ermination; the thick cell-walleda leurone layer, encasing the endosperm;and the pericarp. The bran fractions consist of the pericarp, testa, and hyaline and aleurone layers. By weight, the wheat caryopsis is composed of an outer branny husk (14 -16% of the grain), the germo r embryo (2-3%), and the central endosperm (mainly starch: 81 -84%) (Pomeranz 1988) .
Conventional millingo fw heat grains is based on separating the endosperm(whichproduces white flour when milled)f rom the bran layersa nd embryo.T he aleurone cells, along with the other bran layersand the embryo,a re removed to formt he bran fraction. Although some processing is necessaryfor palatability, safety ande venn utrientb ioavailability (Topping 2007) ,t here has been interest in the potential health benefits of high fibre food products for several years.
In terms of health, epidemiological( as well as experimental) evidence is accumulating to show that fibre may reduce the risk of certain chronic diseases, in particular cardiovascular disease (CVD), metabolic syndrome, type 2d iabetes andc ertain cancers ( Fung 2002; Koh-Banerjee et al. 2004; Sayhoun et al. 2006; Seal2006; de Munter et al. 2007; Schatzkin et al. 2007; Mellen et al. 2009 ).Although it has been suggested that it is the complex combination of components in the wholegrain matrix that may work togethert oi mpart healthbenefits (Slavin 2003; Fardet 2010) ,othershave suggested the particular role of the bran component (Jensen et al. 2004) .Inseveral epidemiological studies, analysis of data obtained for whole grains and adjusted for intake of its constituents (namely cereal bran, germ ande ndosperm) showeda ni ndependent associationo nlyf or thew heat branc omponent (Vitaglione et al. 2008) .
Physiological effectsofw heat bran and wheat germ
Nutritionally,b ran fractions produced by milling are rich in fibre,m inerals, vitamin B6, thiamine, folate andvitamin Eand some phytochemicals, in particular antioxidants such as phenolic compounds (Shewry 2009 ).However, bioavailability is affected by the food matrix as well as processing conditions. Bran is used in the production of brown and wholemeal flours, hencer etainings omeo ft he valuable nutritional components that are depletedw hen these fractions are furtherr emoved in the refinement of white flour.
The physiological effects of wheat brancan be split inton utritional effects (fromt he nutrients present), mechanical effects (mainlyo nt he gastrointestinal tract,due to the fibre content) and antioxidant effects (arising from thep hytonutrientsp resent such as phenolic acid and alkylresorcinols). Ta ble Il ists the major bioactivec ompounds foundi nw holegrain wheat, wheat bran and germfractions.
Studies have reportedt hat the majority of beneficiala ntioxidant phytochemicals (including phenolic acid and alkylresorcinols) in wholewheatg raina re present in the germ/bran fractions. In wholegrain wheat flour, the bran/germf ractions contained8 3% of total phenolic content ( Adom et al. 2005) .C onsequently,t he bran fraction has higher antioxidant activity than other milled fractions (Liyana-Pathirana andShahidi 2007).
Although thea ntioxidant capacity of cereal fractions, such as wheatb ran, is wellr eported, Perez-Jimenez andS aura-Calixto (2005) suggest that the antioxidant capacity maybeunderestimated in the literature, since the laboratorye xtraction methods used do not always allow for ac omplete release of antioxidant compounds, and non-extractable polyphenols (which may be released in the gut after colonic fermentation)with ahigh antioxidant capacity are also often ignored.
Both wheat variety and growing conditions can significantly alter the antioxidant profiles, concentrations andproperties of compounds such as phenolic acids, carotenoids and tocopherols found in wheat brans (Zhoue ta l. 2004; Menga et al. 2010; Shewry et al. 2010 ),a lthoughw heat bran fractions seem to consistentlyr etain theirr adical scavenging and chelating capacities. Additionalw ork has shown that it is the aleurone layer (wheat bran fraction) that consistently hast he highest antioxidant capacity amongw heat fractions andt hatf erulic acidi n particular (a derivative of the phenolic acid cinnamic acid)a ccounts for up to 60% of this antioxidant capacity (Mateo Anson et al. 2008; Vaher et al. 2010) .
It has been suggested that the antioxidant phytochemicals found in wheat bran fractions may modulate cellularo xidative status andp revent biologically important molecules such as DNA, proteins and membranel ipids from oxidative damage, andt hat this consequently plays ar ole in reducing the risk of chronic diseases such as CVD and cancer (Zhou et al. 2004) .
The phenolic antioxidants present in wheat bran havebeen shown to inhibit LDLoxidation, possibly by binding with apolipoprotein-B (Yuetal. 2005; LiyanaPathiranaa nd Shahidi 2007). Alkylresorcinols, another antioxidant found in wheat bran, has been shownt oi nhibit platelet binding to fibrinogen, stimulate thromboxane production and inhibit triglyceride formation, suggesting ap otential role for phenolic compounds found in the branf ractions in CVD (Ross et al. 2004 ).
More recent work has also shown that wheat bran phenolic compounds, such as feruloyl oligosaccharides, protect against free radical-induced oxidative damage in human erythrocytes (Wang 2009 Arabinoxylan is an important source of antioxidant phenolic compounds, includinga lkylresorcinols and phenolic acids (including ferulic acid). Whendelivered to the colon complexed with arabinoxylan, these phenolic compounds maybereleased by fermentation to havep otentially beneficial effects (Vitaglione et al. 2008) .A lkylresorcinols can be incorporated intoc ell membranes and play ar ole in vivo,i nm embrane function.
Ferulic acid likemost of the phenolic compounds in wholegrain wheat fractions exists in bound form (approximately 76%), usually bound to arabinoxylans ando ther indigestible polysaccharides( Liu2 007; Mateo Anson et al. 2009 ).Although processing (such as thermal treatments and fermentation) mayimprove the release of ferulic acid ando therb ound phenolics, some authorsq uestiont he availability of such phenolics for absorption in the gastrointestinal tract (MateoA nson et al.2 009).O therss uggest the importanceofbound phytochemicals, andthat unlike phytochemicalsf rom fruit and vegetables (whicha re mainly in free or soluble conjugate forms and readily available in the upper gastrointestinal tract) theym ay haveamore site-specific effect in the colon, suggesting that wheat bran may impartg reater health benefits when consumed as parto fawiderd iet ( Liu 2007) . Although most of the phenolics in wheat brana re bound to cell wall materials that are difficult to digest, theymay reach the colon in tact, where they undergo colonicdigestion by microflora andconsequently may exertt heir potentialh ealthb enefits locally. For example, gastrointestinal esterase can release ferulic acid (a potent antioxidant) from bran (Andreasen et al. 2001) . Saura-Calixto( 2011) points outt hatt he presence of bound antioxidants, such as polyphenols andc arotenoids, in dietaryfi bre may significantly affectthe physiological properties and health effectof dietary fibre,a nd thatp erhaps dietaryfi bre and antioxidants should be approachedjointly in nutrition andh ealth studies because of their common fate in the gut.
Other biologically important components in wholegrain fractions include sulphur containing amino acids (methionine andc ystine). These two amino acids are found in higher levels in the wheat bran (0.6%) (Fardet 2010) . Both methionine and cysteinea re precursorsofglutathione (an intracellular antioxidant) andc ontribute to the control of cell oxidative status (Metayer et al.2 008) .L ignans,a lso found in wheat bran, havebeen shown to have anti-tumour properties in mice and humanc ells that mayb em ediated by cytostatic and apoptotic mechanisms (Qu et al. 2005) .
Wheat bran and wheat germf ractions also contain almost allo ft he B-groupv itamins: thiamine, riboflavin, niacin, pantothenic acid, pyridoxine, biotin andf olates,w ithw heat bran andw heat germ fractions containing about3 0.3 mg and1 2.3 mg B vitamins/100 gr espectively.T hey are also as ourceo f vitamin Eand the carotenoids. Other bioactives found in wholegrain fractions (such as ferulica cid,m agnesium, zinc,c opper, inositols, policosanol and melatonin)h avea lso beens uggested to have ar ole in promoting mental health (Fardet 2010) .
Phytic acida nd wheat bran
The bioavailability of minerals in wheat branisu nder debate because of the presence of the 'anti -nutrient' phytic acid.
Phytic acid is an aturally occurring organic compound present in cereals, usually as myoinositol hexaphosphate. It is concentrated in the external coversinthe pericarpand aleurone layer of the grain as well as, at lower levels, in the germ ( Cheryan 1980) ; 90% of the phytic acid in grainisinthe aleurone layer with 10% in the embryo (Dost andT okul 2005) . Consequently,t he amount of phytic acid is greatly determined by the fractions removed during milling: white flour has almost no phytate. Wheat contains around 1.13% phytate (dryweight) (Cheryan 1980) or 3% expressed as grossp roduct( Pointillart and Gueguen1992).
Phytic acid content ranges from 200 to 400 mg/100 g in refined flour and 600 -1000 mg/100 ginwhole flour (Febles et al. 2002) .Inwheat bran, it ranges from 3116 to 5839 mg/100 gd ry weight (Bilgicli andI banoglu 2007) .A na verage 2-3t ablespoon serving of commercial wheat bran is estimated to contain 200 -300 mg of phytic acid. Thereisalack of data on average daily intakes of phytic acid. In Spain, where daily bread consumptioni sc alculated at 151 g/day,p hytic acid intakefrom bread is estimated at 159 mg/day (if white bread was consumed) to 350 mg/day (wholewheat bread) (Garcia-Estepa et al. 1999) .O nt he basis of a similar calculation, phytic acid intake is estimated at 96 g/day (if white bread is consumed) to 211 mg/day (wholemeal bread).
Most of the minerals in wheat kernels are presentas complexes with phytic acid.M aturew heat grain has high phytase activity,hydrolysing phytates andmaking the minerals nutritionally available (Brinch-Pedersen et al. 2002) .H owever, the presence of phytate has been consideredasananti-nutrient in humans because of its effect on the bioavailability of iron, magnesium, zinc and calcium.Whilethe mechanism is not entirely understood, it is suggestedt hat phytic acid binds strongly with these mineralc ations to formp hytatemineral complexes,c hanging their solubility,f unctionality absorption and digestibility (Rickard and Thompson 1997) . Consequently,the complex cannot be absorbedo re asily hydrolysedb yt he human body and so there is an adversee ffecto nb ioavailabilityo f minerals (Harland and Harland1980).
Humans tudies haves hown thatt he absorption of calcium, iron, magnesium andz inc is significantly loweri nd iets high in phytic acid (Kies1 985 Historical studies have shown ad ecreased absorption of calciuma fter phytic acid was added to white bread (Harris1 955). More recently, studies have shown that wheat bran, when digested with milk (e.g. as breakfast cereal), reduces the absorbability of the calcium in milk (Weaver et al. 1991) ,possibly through physical entrapment, adsorption or ionic binding. We aver et al. (1996) showed, in ar andomized crossover study of healthy women, that with comparable calcium load,f ractionalc alcium absorptionw as significantly lower when the diet was supplemented with 16 g/day wheat bran; the impact of wheat bran on calcium availability continued even at calciumloads as high as 75 mmol, suggestingt hat the ability of wheat brant ob ind calciumi sn ot saturated at doses higher than those provided by most meals. Consequently,i t has been suggested that high intakes of insoluble fibre mayc ontribute to osteoporosis. Whether this is of physiological significance in termso fb oneh ealth has been explored further. Short-term( 4w eeks) and longer-term( 2y ears) studiesh aved emonstrated that wheat brani nt he dieth ad no significant effecto n bonet urnover markersi ny oung and older women (Zitterman et al. 1999; Chen et al. 2004) .T herefore, despite the negative effects of wheat bran on calcium bioavailability,there is insufficient evidence to suggest that it has any detrimental effectonbone metabolism, causing accelerated bone loss.
Zinc absorption follows adose-dependent response with phytate (Naverte ta l. 1985).H unt et al. (2008) showed that diets higher in phytic acid may necessitate greater intakes of zinc, and suggested that humans only minimally adapt to increase zinc absorption from diets high in phytic acid with ap hytate:zinc ratio . 15 -20. However, if the diet is low in phytica cid, absorption of zinc is up-regulated when zinc intakes are habitually low.C urrently,U Sa nd Canadian diets haveatypicalp hytate: zinc ratio of 2, which would make the current zinc intakes of 7.1 mg (women) and 9.0 mg (men) adequate. Meeting current US recommendations on increasing wholegrain consumption would lead to ap hytate: zinc ratio of 8, which Hunt et al.( 2008) calculate to equate to az inc intakeo f 9.2 mg and 13.4 mg for women andmen respectively. There are currently no data available on the UK dietary phytate: zinc ratio, but assuming it is similar to the US ratio, current UK intakes of zinc (7.8 mg and 10.1 mg for women andmen respectively; meeting the RNI of 7.0 and9 .5); it could be anticipated that increasing consumptiono fw hole grains (and, consequently,ah igherw heat bran intake) could have a negative impactonzinc status in UK adults: RNIs may need to be adjusted accordingly.
There is no consensus on the effect of wheat bran on iron bioavailability.A nimals tudies have shown that iron from wheat branf orms am onoferricp hytate, which is highly available,p ossibly because it remains soluble at intestinalp Ha nd hydrolyses to aid absorption, whereas other iron -phytate complexes (e.g. from oat bran) have been shown to be unavailable (Fly andC zarnecki-Maulden 1996) .A tm oderate levels (providing 2-4% of totald ietaryfi bre), the authors concluded that iron from wheat bran is readily available.H owever, some human studies have shown ad ecrease in iron retention when fed wheat bran (Cook et al. 1983; Hallberg et al. 1987) ,w hile others like Dintzis et al. (1985) showed no change. Indeed, according to Gibson et al. (2006) , phytic acid begins to lose its inhibitory effecto ni ron at ratios of , 1.0:1.0 (phytate:iron), but the effecti ss till present as low as 0.2:1.0.
There is apotential public health nutritionproblem of iron and zinc deficiencyfor populations whose diets are mainly cereal andl egume-based, or those whose diets are marginal in essential minerals (Raboy 2001) . Vegetarians, whose intakes of phytate are typically highert han those of omnivores, appear to be most affected by phytate-containing foods as despite having similar intakes of,e.g., iron and zinc as omnivores the bioavailability may be compromised (Agte et al. 1999) . Nevertheless,most studies of vegetarians indicate that iron andz inc status is adequate, and it appearst hat theremay be some degree of physiological adaption of the gastrointestinal tract to increase absorption of trace elements and so overcome the presence of phytic acid (Gibson 1994) .
The degree to whichp hytic acid can influence nutritional status, however, is dependant on anumber of food andh ost-related factors: the amountd igested in the gut, the content of phytate andm inerals in the food and the nutritional status (replete or deficient in a nutrient), and the overall diet of the individual can all havea ni mpacto nm ineralb ioavailability ( McKevith 2004) .
Processing significantly affects the bioavailability of minerals in the presence of phytates; germination, fermentation and baking,l eading to phytate hydrolysis, haveb een shown to have ab eneficial impacto n mineral bioavailability (Watzke 1998) .
Animals tudies haves hown that otherc omponents of fibre,i nulina nd oligofructose, act as potent enhancerso fm ineralb ioavailabilityi np lant-derived foodsa nd human studies, havep artially confirmed these findings (Coudray et al. 1997 ; Vand en Heuvel et al.1 999; Vitali et al.2 008). Furthermore, preliminaryh uman studies havea lso shown that carotenoids (lycopene,l utein andz eaxanthin) increased iron absorption from aw heat-based breakfast by 8.4 -14.4% (Garcia-Casal 2006) , but this used white wheat flour, likelyt ob el ow in phytate.
However, the presence of phytic acid does not only implynutritionalproblems. In contrast to the reported anti-nutrient properties of phytic acid,s tudies have shown apotentially beneficial role for the compound. In particular, phytic acid is reported to lead to delayed post-prandial absorption (Yoon et al. 1983) ,d ecrease in plasma cholesterol and triglycerides (Katayama 1995) ,i nhibition of hypercalcuria and renal stone development (Grases et al.1 998, 2000) Huang et al. 1997) ,t he latter being purported to be owing to antioxidant action. The antioxidant functions of phytic acid are thought to result mainly from its iron andc opperc helating properties, althoughm echanisms are not yet fully understood (Minihane and Rimbach 2002) .
Dietaryfi bre and wheat bran
Thefibrecontent of thewholewheatgrain ranges from 11.6%t o1 2.7% dryw eight ( Carson andE dwards 2009) . Most of thefibrethatisinthe outerlayers of the grain (pericarp ands eedc oat) is typicallyc alledwheat bran.Itisone of therichest sourcesoffibre, 46% is nonstarch polysaccharide (NSP). Them ainN SPsp resent area rabinoxylan, cellulosea nd beta-glucant hata re respectively 70%, 24%and 6% of theNSP of thebran (Maesand Delcour2002).The concentrationofsoluble fibre in wheati ssignificantlylessthaninother cereals, e.g. barley ando ats, 3-11%a nd 3-7%r espectively, compared with less than 1% in wheat( dryw eight) (Wood1 997).The amount andtypeoffibreinw heat, andspecifically in wheatbran, is showninT able II.
Wheat consumption in the diet
Cereals are staplef oodsi nw estern countries, and typically contribute about5 0% of dietaryfi bre intake (Lambo et al. 2005) . The recommendation that cereals formt he basis of the diet is well recognized in the majority of countries with dietaryguidelines including most EU memberstates,the USAand Canada.
Ta bleI II shows the cereal andc ereal product consumptionb ya dults in Francea nd also the %c ontribution to average intakes of energy andfi bre (AFSSA 2009).Similar data for UK adults (Hoare et al. 2004) show that cereal products contribute 37% of fibre intake and 28% of total kcal intake, while in Belgium it is estimated that average consumption is 186.5 g/day,with cereal and cereal products contributing 22.3% to total energy and 34% to fibre intakes (De Vriese et al. 2005) .
Wheat is the most heavily consumedg rain in the world. Forexample, in the UK wheat consumptionis more than 10 times as mucha sr ice( which is mostly consumed as white rice), andoats(419,000 tonnesin 2008/2009), or maize (305,000 tonnes).U sage of wheat for flour and starch milling in 2008/2009 was 6.1 milliont onnes. To talh uman andi ndustrial consumptionofwheat for the same year was estimated at 6.836 million tonnes (FAO 2010), implying wheat consumptiono fn early1 10 kg per capita. Data for consumptiono fw heat bran pers e are not currently available;h owever, bran for human consumptioni s produced by flour millersr athert hano ther wheat users. It is estimated that it accounts for approximately 10% of their total outputofco-products (i.e. products othert han flour); this woulda mountt o1 12,000 tonnesin2008/2009(Alex Waugh, NABIM, personal communication).W heat is consumed in Europe typically as bread, pasta, breakfast cereals andbiscuits, cakesa nd pastries. Withi nformation takenf rom manufacturer'sw ebites, Ta ble IV shows sources of wheat bran in the diet.
Dietaryfi bre and wheat bran intakes
The European-recommended dietaryfi bre intake is 25 g/day based on the AOAC method. In the UK, fibre recommendations basedo nN SP are set at 18 g/day. Forchildren, this varies andthe general rule for health care professionals is age of child plus 5g.A verage dietaryfi bre intakes in Europe range from 10 to 20 g/day in young children andf rom 16 to 29 g/day in adults (European Food Safety Authority [EFSA] 2010). These recommendations cover totalfi bre intakeand there is currently no established guidelines that differentiate between fibre type and source.
Fibre intakes are ascertainedthrough dietarysurvey eitherafull dietaryr ecall including portion sizes,d iet diarieso rf oodf requency questionnaires. These methods are often time-consuming andw hend ealing with al arge datasett ake ag reat deal of time, effort, attention to detail andc onsistencyo fm ethodology. The DINE questionnaire (Roe et al. 1994 ) was developed to be administered ands cored in under 10 minutes by primaryc are staff without specialized nutritional knowledge. The questionnaire gives an outputoflow,medium or high for fatand fibre intakes. This validated questionnaire is in wide use and is currently being modified to provide am ore numeric value for fibre intake basedo nm ore modernA OAC fibre values.
The majority of data from cohorta nd epidemiological studiesu sedt od emonstrate thep otential healthb enefits of wholegrain consumptionh aveb een derived from dietarya ssessment methods that were not originally designed to quantify wholegrain intakes -t he majority relied on semi-quantitativef ood frequencyq uestionnaires using al imited range of wholegrain foodsw ith varying descriptions of wholegrain foods (Seal 2006) .
Wheat bran and health benefits
Studies haves hown that wheat branm ay havea beneficiale ffecto nt he prevention of diseases, Ta ble II. Fibre concentration in wheat and wheat bran. including some cancers( in particularc olorectal cancer), CVD, obesitya nd some gastrointestinal diseases, including diverticular disease, constipation andirritable bowel syndrome (IBS) (Fardet 2010) .
Wheat bran and cancer
Bowel cancer is amajor cause of mortality in the UK. there was some evidence of decreased numbero f polyps and therefore reduced risk of cancer where patients consumed at least 50% of their prescribed fibre.
In another randomized control trial of patients following colonicpolypremoval surgery, Alberts et al. (1996) found that ad iet supplemented with wheat bran cereal (13.5 g/day) reduced faecal bilea cid concentration. Bile acids are consideredt op lay a role in colorectal cancer risk. However, later followup studies, after 3y ears( Albertse ta l. 1997),f ailed to show any significant effecto ft he high wheat bran diet on the development of colorectal adenomas.
The Australian PolypP revention Project (Maclennane ta l. 1995) reportedt hatalow fatw heat bran supplemented diet( 25 gw heat bran/day) reduced the incidence of large colorectal adenomas,s uggesting that wheat bran, alongside al ow-fat diet, inhibitst he development of malignanta denomas. These studies support, to somee xtent, that aw heat bran supplementedd iet may be protective against colorectal cancer and polyps.
Furthermore, animal studies have demonstrated a significant protective effecto fw heat brano nc olon carcinogenesis in rats fed ah igh-fat western-style diet (Alabaster et al. 1996) .W heat bran, in addition to psyllium (50:50),l ed to enhanced protection and synergistic effects may inhibit different phases of the carcinogenicp rocess, with wheat bran phytic acid inhibiting earlier stages and psyllium inhibiting later stages (Alabaster et al. 1993) .
Thep rotectivem echanismso fw heat bran, especially in terms of colon cancer,f all into three categories (Lupton and Turner 1999) . The first is the established effect on dilutiono fp otential carcinogens andp romoterso fc arcinogens -amore bulkys tool reduces access to the cells lining the colon. Second, it is well established that wheat bran accelerates transit of faecal material through the colon, such that rapid transit reduces accesso ft he colonice pithelial cells to faecal constituents. However, notall fibre has the same ability to dilute contents of the lumen, or the same potential to accelerate colonict ransit. Animal models haveshown that wheat bran is the bestdiluterand has the shortest transit time comparedw ith pectin, guar gum,o at bran and cellulose (Gazzaniga and Lupton 1987; Lupton and Meacher1 988) .
The third is the effectoffermentation of wheat bran to ShortChainFatty Acids(SCFA) (including butyric acid)t hroughout the colon. Studies have found that SCFAs may modulate carcinogenesis through their effects on proliferation, differentiation and apoptosis of colonocytes,a sw ell as stimulation of the immune system (Topping and Clifton 2001; Schley and Field 2002) . Clausen et al. (1991) h aves hown that wheat bran doublest he productiono fS CFAs and in vitro fermentation, resulted in reduced productiono f butyrate in subjects with colonic adenomas or suffering from colon cancers. Rat model studies haveshown that butyric acid maystimulate, ratherthan inhibit colonic epithelial cell proliferation (Lupton andK urtz 1993) . The authorsc oncluded that the effect of SCFAs on colonocytes is different in normal cellsf rom transformedc ells. Butyrates eems to inhibit growth of transferredc ells while enhancing proliferationi n normal human and rat mucosa.
An animal model study (Zoran et al. 1997) showed that although oat bran produces more butyric acid in the colon, wheat bran is more protective against colon carcinogenesis, reducing incidence of tumours. In a study involving patientswith ahistory of colon cancer fed 13.5 go fw heat bran fibre for 2m onths, Alberts et al.( 1990) concluded that wheat bran fibre supplementationc an inhibit DNAs ynthesis and epithelial cell proliferation within rectal mucosa crypts of patients at high risk for colon cancer.
Finally,s tudiesh aves hownt hat phytica cidm ay blockP I-3 kinase activation, which acceleratesa poptosis andm ay be protectivea gainst colorectal cancer development (Huang et al. 1997) . Other data suggest that some of the phytochemicalc ompounds in wheat bran,i ncluding beta-sitosterol, maya lso have ab eneficiale ffect on colon cancer (Waliszewski et al. 1997) Colon cancer mayn ot be the only cancer linkedt o fibre.Ap otentially protective effecto ffi bre has also been observedi nb reastc ancer research. Cade et al. (2007) suggest that in pre-menopausal women total fibre is protective against breastc ancer,i np articular fibre from cereals andp ossibly fruit. Their work that involveda nalysis of al arge cohort of adult women found that in pre-menopausal, but not post-menopausal, womenastatistically significant inverse relationship was found between total fibre intake and risk of breast cancer. The top quintile of fibre intake was associated with ah azard ratio of 0.48 [95% confidence interval( CI)0 .24 -0.96] compared with the lowestq uintile. Pre-menopausally,fi bre from cerealsw as inversely associatedw ith risk of breast cancer and fibre from fruit had ab orderline inverse relationship.Mechanisms of effectare postulative, but plausible mechanisms could be the role in fibre and weight management and the potential for fibre to bind with estrogens (Goldin et al. 1986; Rose et al. 1991; Stoll 1996) .
Wheat bran and CVD
The cardiovascular benefits from wholegrains are only supported where the wholegrain contains significant amounts of fibre or bran. In ad ouble-blind placebocontrolled crossover study of wholegrain cereal and wheatb ran, Costabilee ta l. (2008) reported a significant reduction in total serum cholesterol. After consuming aw heat bran-based breakfast cereal for 3w eeks, containing approximately 13.5 go ffi bre, serum cholesterolw as reduced from5 .576 to 4.385 mmol/l in those participants with the highest quintileo fs erum cholesterol.F urthermore,n o reduction was found in beneficial HDL-C, suggesting beneficial effects on CVD risk.
In ac ross-sectional analysis of US adolescents, Carlson et al. (2011) found that increasing dietaryfibre was associated with lower risk of metabolic syndrome. In aprospective cohortstudy of 42,850males, Jensen et al. (2004) examined the effectofa ddedbraninthe diet, in addition to wholegrain intakes, on risk of coronaryh eartd isease (CHD). However, while the type of bran was noti dentified, the authorsr eported that it was predominantly wheat and oat bran. The relative risk of CHD in menwith the highest intake of added bran was 0.70 (95% CI: 0.60 -0.82) compared with men who had no addedb ran. He et al. (2010) recently reported on the mortality and CVD-specific mortality of 7822 women with type 2diabetes from the Nurses HealthS tudy.C ompared with those women with the lowest intake of bran, womenwith the highest intake havea ll-cause mortality relative risk of 0.72 (95%C I: 0.56 -0.92) and relative risk for CVDspecific mortality was 0.65 (95% CI: 0.43 -0.99).
Wheat bran and obesity
Evidence from epidemiological studies suggests an inverse relationship between intake of dietaryfibre and weight gain and obesity,w hile fibre consumption is associated with increased satiety anddecreased energy intake (Freeland et al. 2009 ).Ithas also been proposed that dietary fibre increases faecal energy loss (Astrup et al. 2010 ). Viscous fibre is thought to exert the greateste ffecto na ppetite regulation, but studies using wheat bran havea lso reported ar eduction in food intake following atestmeal with wheat bran, but it is not clear whether this effectislong-lasting in terms of management of obesity (Freeland et al. 2009 ).
The effecto fw heat bran on postprandial appetiteregulating hormones is less well studied, althougha recentanimal study (Neyrinck et al. 2008 ) investigated the effecto fw heat bran on GLP-1 secretion, and found no effect on bodyw eight, adipose tissue mass, glucose or insulin resistance. However, this study did demonstrate an impacto fw heat brano ni nflammation, including decreased inflammatorycytokines.
Wheat bran and digestive health
In termso fd igestive health, wheat bran can offer several beneficial effects. Wheat bran has an effect on faecal bulking,delays gastric emptying and accelerates small bowel transit (McIntyre et al. 1997) . Generally, faecal bulking has beenl inked with an umbero f potentially beneficial effects as summarized in Ta ble V.
Faecal bulk is ar esult of multiple interactions between the food, the host andt he gut ecosystem (Eastwood 1993) .T he bulking effects of fibre are greatestw ith cereal fibre, especially products high in insoluble NSP such as wheat bran( To pping 2007) Wheat bran is so effective at faecal bulking thatitisthe reference against whicho therf oods are measured for their faecal bulking efficiency (Monro 2002) .
The mechanismbywhich wheat bran increases stool weight has been studied by Chen et al. (1998) , who showed that a30g/day supplementwas associated with amean wetstool weight increase of 52.4 g/day.Wheat branw as shown to increase faecal concentrations of sugars( glucose, arabinose and xylose)a nd mass of plant material more than oat bran, althougho at bran had agreater effectonincreasing bacterial mass. With wheat bran, the increase in stool weight was largely a result of undigested plantfi bre( 50 -60%)b ut increased bacteria contributed1 2-17% of the increase. These studies reportedn oi ncrease in the proportion of water in the stool, which supports other reports (Cummings 1993) .
Both the European Food Safety Authority and the UK Scientific AdvisoryC ommittee conclude that the mean increase in daily faecal weight is approximately 5g per 1g wheat branc onsumedc ompared to other fibress ucha sf ruit and vegetables (4.1 g/g), gums including psyllium (4 g/g),soya products (2.5 g/g) and pectinleast of all (1.2 g/g) (SACN 2008) . Transitt ime is also affected by wheat bran. Payler et al. (1975) showed that adding 20 g/day of wheat branr educed transit time from 2.75 to 2.0 days, and the authorsalso confirmed thatwhile bran accelerates slow transit time, it may also slow down fast transit time (that is less than 1day). The likely mechanism for the increase in transit time is the high content of cellulose and hemicelluloses in wheat bran, which softenand expandt he stool.
Insoluble fibre (the maincomponent of wheat bran) is notr eadily brokend ownb yg astrointestinal microflora and it increases faecal bulk,s hortening colonictransit time. Soluble fibre dissolves in water to formgel and maybedigested by the colonic microflora, increasing bacterial numbersand thus increasing bulk.
Wheat bran and IBS
Increasing fibre intake hasb een suggested as an initial treatment forI BS,a lthough therea re conflicting data on itseffectiveness.Conversely, wheatisoften associated with increaseds ymptomsa nd reducing, butn ot necessarilyexcluding, wheati ntakemay be beneficialin IBSm anagement ( NICE 2008) . Nevertheless,B ijkerk et al. (2003 Nevertheless,B ijkerk et al. ( , 2009 reported that most GPsrecommend an increase in fibre forp atients with IBS, advisingt he additiono fi nsoluble fibre in thef ormo fb ran. Am ore recentr andomizedc ontrolledt rial showedt hatw hile soluble fibre (psyllium)w as effective at reducing symptomso fI BS,w heat bran (20g/day)w as not, especiallyatthe onset of treatment (Bijkerketal. 2009 ).
Ameta-analysis of the effect of wheat bran on stool weight and transit time (Muller-Lissner 1988) showed that wheat brani ncreased stool weight andd ecreased transit time in healthy controls and patients with IBS andchronic constipation. The NICE (2008) guideline consensus on IBS states that wheat branshouldnot be recommended for peoplewith IBS as it is ineffective in the management of symptoms,and may even increase symptoms for some people-an increase in fibre, if neededshouldb ei nt he formo fs oluble fibre.
Other gut conditions, however, mayb eh elped by wheat bran. Painteretal. (1972) showed that there was marked relief from symptoms of diverticular disease with ahigh residue, low sugar diet, including 12 -14g of rawu nprocessed wheatb ranp er day( range: 3-45g). More recently, aCochrane review of evidence has found that adding more wheat and branfibre to the diet was effective at alleviating constipation during pregnancy, increasing frequency of defaecation, and is preferable to taking stimulant laxatives, which may haveundesired side effects (Jewell andY oung 2001) .
Wheat bran as ap rebiotic
Colonic microflora has ap rofound effecto nh ealth. The gut flora components can be modified by dietary means,s uch as increasing prebiotic intake. Prebiotics are defineda sn on-digestible food ingredients that beneficially affect host health by selectively stimulating the growth and/or activity of one or al imitedn umber of bacteria in the colon (Gibson and Roberfroid 1995) . It is not the prebiotici tself that brings aboutc hange, but its effect on the gut microflora (Wangetal. 2009). There is ag rowing body of evidence to supportt he beneficial health effects of prebiotics on bowel health and risk of colon cancer andC VD (Costabile et al. 2008) .Prebiotic components of dietary fibre in wheat bran( including beta-glucans) mayb ef ermentedb y colonicm icroflora to form SCFA,r esulting in physiological changes to the coloniccontents, affecting bulking,water retention capacity andviscosity.Butyric acid is one suchS CFAt hat has been recognized as a fuelfor colonocytes andalso contributes to faecal pH, influencing colonic function Costabile et al. (2008) found amore modest change in gutmicroflora after consuming awheat brancereal, compared with awholegrain cereal.Markersofcolonic metabolic output (including ferulic acid and SCFAs) also increased.
Wheat bran and health claims within the European Union
TheE FSAh as been taskedt op reapprove any nutrition and health claim for market in the EU.I n this relatively early stage of the legislation, the EFSA is working through al ist of over 40,000 so-called 'generally accepted claims'. Eightyp ercent of these claimsh aveb een rejectedo ns everal grounds from insufficient characterization of the food to causea nd effectr elationship not being established. In October 2010, the EFSA panel passed opinion on two claims pertaining to the benefits of wheat bran. The two approved claims are as follows:
Increase in faecal bulk The claimed effecti s' intestinal health: faecal bulking'. The targetp opulation is assumed to be the general population. The panel considerst hat an increase in faecal bulk might be ab eneficial physiological effect. In weighing the evidence, the panel took into account that the majority of the humani ntervention studies showed ac onsistent effecto fw heat bran fibre on faecal bulk and that no threshold dose for the effectcan be established. Al inear dose dependent relationship was demonstrated in several studies. The claimed effects are 'guth ealth' and' intestinal transit time, intestinal health'.T he target population is assumed to be the general population. In thec ontext of thec larifications providedb y Member States, the panel assumes that the claimed effectreferstoareduction in intestinal transit time. The panel considers that ar eduction in intestinal transit time withint he normal range might be a beneficial physiological effect. In weighing the evidence, the panel took into account that the studies provided consistentlyi ndicated that wheat branfi bre consumeda ta na mounto fa tl east 10 g/day decreased intestinal transit time.
Wheat bran is easy to characterize and the evidence for thee ffect on stool weight andt ransit time is unequivocal. The conditions of use for the claim, i.e. the amountmanufacturersneed to haveinthe food in order to make the claim, still need to be approved by the European Commission.
Summary
In conclusion like many European countries, UK dietary intakes of fibre are in region of 13 gv ersus the dietaryr ecommendation of 18 g( 25 gA OAC). Promotion of foodshigh in wheat bran will helpachieve this recommendation. Given the prevalence of constipation, less than desirable stoolw eight ands low digestivet ransit health recommendations should promote and include advice on wheat bran fibre as it is establishedt ob et he benchmark in promoting laxation andm ore expedient transit time. This is endorsed by European Food Safety Authority who has recently approved two health claims for wheat bran for faecal bulking andt ransit time. In addition, there is now strong evidence that fibre,and in particular wheat branfi bre,m ay have health benefits in terms of prevention of diet-related diseases.
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